NCT01411189View on ClinicalTrials.gov

Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

June 30, 2012

Conditions
Gastric CancerColon Nos Polypectomy Tubular AdenomaGastric Adenoma
Interventions
DRUG

Menthol

20 mL NPO-11 in prefilled syringe

Trial Locations (1)

101-0031

Nihon Pharmaceutical Co., Ltd, Tokyo

Sponsors
All Listed Sponsors
lead

Nihon Pharmaceutical Co., Ltd

INDUSTRY

NCT01411189 - Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy | Biotech Hunter | Biotech Hunter